封面
市場調查報告書
商品編碼
1836369

2032 年足踝創傷市場預測:按產品、損傷類型、治療方法、分銷管道、應用、最終用戶和地區進行的全球分析

Foot And Ankle Trauma Market Forecasts to 2032 - Global Analysis By Product, Injury Type, Treatment, Distribution Channel, Application, End User and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據,全球足踝創傷市場預計在 2025 年達到 20.2 億美元,到 2032 年將達到 36.2 億美元,預測期內的複合年成長率為 8.7%。

足踝損傷涉及足踝骨骼、肌肉、韌帶或軟組織的損傷,通常由跌倒、運動傷害或意外事故造成。這些損傷範圍從輕微扭傷到複雜的骨折和脫位,需要早期醫學評估。有效的治療,無論是手術治療還是保守治療,對於確保康復、維持活動能力以及預防慢性不適和殘疾等長期問題都至關重要。

根據世界衛生組織 2025 年 5 月發表的報告,每年約有 119 萬人死亡,2,000 萬至 5,000 萬人遭受非致命傷害。

老年人口不斷增加

隨著與老齡化相關的肌肉骨骼疾病日益普遍,人口老化日益加劇,對足踝損傷治療的需求也顯著增加。老年人的骨質疏鬆症、關節炎和骨骼密度下降導致骨折率上升,尤其是在踝關節。醫療保健系統正積極應對這項挑戰,投資於專為老年患者量身打造的先進手術器械。微創手術和機器人輔助手術日益受到青睞,可望縮短復原時間並提高精準度。影像和診斷技術的創新使得老年創傷病例能夠更早發現和介入。隨著全球預期壽命的延長,對專業整形外科解決方案的需求持續成長。

專業技能人才短缺

許多地區,尤其是開發中國家,在吸引和留住能夠執行複雜外科手術的熟練人才方面面臨挑戰。將人工智慧和機器人系統融入外科手術工作流程需要額外的培訓,這進一步擴大了技能差距。規模較小的醫療機構由於缺乏熟練的醫護人員,難以實施先進技術。人才短缺減緩了創新治療方法的採用,並延誤了病患照護。解決這個問題需要在醫學教育、認證課程和全球人才流動方面共同努力。

微創手術的普及率不斷提高

微創手術的轉變正在為足踝創傷治療開闢新的成長途徑。這些手術對患者和醫護人員都極具吸引力,因為它們可以減輕術後疼痛、加速癒合速度並降低感染風險。內視鏡工具、3D導航系統和機器人平台等技術進步正在提高手術精準度。醫院和門診中心擴大投資於專為微創干預設計的緊湊型模組化設備。新興趨勢包括擴增實境輔助手術和人工智慧驅動的術前規劃。隨著報銷政策的不斷發展以支持這些手術,預計這些手術在全球市場的普及將加速。

來自替代療法的競爭

再生醫學、物理復健和矯正器具等替代療法對足踝損傷的外科手術介入構成了競爭威脅。幹細胞療法和富血小板血漿注射因其非侵入性且具有促進自然癒合的潛力而日益普及。穿戴式科技和智慧矯正器具也正在成為治療輕微骨折和扭傷的有效工具。這些替代方案通常對尋求創傷較小、恢復時間較短的治療方案的患者更具吸引力。遠端醫療醫療和遠距物理治療的興起進一步擴大了非手術治療的可近性。為了保持競爭力,外科解決方案供應商必須強調卓越的療效和長期效益。

COVID-19的影響:

新冠疫情擾亂了外科護理的發展,導致擇期手術延後,創傷病例減少。封鎖和供應鏈中斷導致必需手術器械和植入短缺。然而,這場危機加速了數位醫療技術的普及,例如遠距離診斷和虛擬手術計畫。醫院開始將遠端醫療平台與基於人工智慧的分診系統結合,以管理患者流量並優先處理緊急病例。疫情後的復甦策略目前專注於建立有韌性的供應鏈、自動化手術工作流程以及分散醫療服務。

踝關節骨折預計將成為預測期內最大的病例

由於踝關節骨折在所有年齡層的發生率都很高,預計在預測期內將佔據最大的市場佔有率。運動傷害、跌倒和機動車事故是踝關節創傷的主要原因,推動了對手術修復工具的需求。醫院擴大使用先進的固定裝置,例如生物可吸收螺絲和鎖定鋼板,以改善療效。術中CT和MRI等影像技術的創新正在提高踝關節手術的精準度。新興趨勢包括個人化植入和根據個體解剖結構量身定做的3D列印骨支架。隨著認知度的提高和診斷能力的提高,踝關節骨折將繼續引領市場佔有率。

預計醫院部門在預測期內的複合年成長率最高

在基礎設施升級和技術應用的推動下,醫院領域預計將在預測期內實現最高成長率。這些機構正在投資機器人手術系統、人工智慧診斷和智慧手術室,以提高手術效率。電子健康記錄與雲端基礎庫存系統的整合正在簡化病患管理和資源配置。醫院也在擴大創傷中心和整形外科,以滿足日益成長的需求。關鍵進展包括與設備製造商合作,以實現即時數據分析和遠端監控。

佔比最大的地區:

預計亞太地區將在預測期內佔據最大的市場佔有率,這得益於醫療保健的快速擴張和外科手術需求的不斷成長。中國、印度和日本等國家正大力投資醫院現代化和醫療設備的本地生產。政府舉措正在推動進口替代並獎勵外科技術的國內創新。該地區正在廣泛採用機器人輔助手術和基於人工智慧的診斷平台。全球原始設備製造商和本地公司之間的策略合作夥伴關係正在加速技術轉移和市場滲透。在不斷壯大的中產階級和老齡化人口的推動下,亞太地區在產量和基礎設施發展方面繼續保持領先地位。

複合年成長率最高的地區:

預計北美將在預測期內實現最高的複合年成長率。美國和加拿大是智慧手術室、人工智慧診斷和機器人輔助整形外科手術領域的先驅。監管機構正在簡化下一代手術器械的核准途徑,以加快其市場准入速度。醫院正在採用基於物聯網的資產追蹤和預測分析來最佳化手術工作流程。該地區受益於強大的報銷框架和患者對先進治療方案日益成長的認知。

提供免費客製化:

此報告的訂閱者可以使用以下免費自訂選項之一:

  • 公司簡介
    • 對最多三家其他市場公司進行全面分析
    • 主要企業的SWOT分析(最多3家公司)
  • 區域細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率(註:基於可行性檢查)
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球足部及踝關節損傷市場(按產品)

  • 整形外科植入和器械
    • 鋼板和螺絲
    • 外固定裝置
    • 髓內釘
  • 支持和支持
  • 義肢
  • 其他產品

6. 全球足部及踝關節損傷市場(依損傷類型)

  • 後足骨折
  • 踝關節骨折
  • 中足和 Lisfranc 損傷
  • 前足骨折
  • 脫臼和複雜性損傷
  • 韌帶損傷和不穩定

7. 全球足部及踝關節損傷市場(依治療方法)

  • 切開復位固定術(ORIF)
  • 非手術治療
  • 微創固定
  • 修復和重組手術
  • 外固定手術
  • 關節融合術

8. 全球足部及踝關節損傷市場(按分銷管道)

  • 直銷
  • 線上平台
  • 分銷商和批發商
  • 集團採購組織(GPO)

9. 全球足踝損傷市場(按應用)

  • 外傷和細微骨折
  • 韌帶損傷
  • 錯位
  • 神經系統疾病
  • 類風濕性關節炎和骨關節炎
  • 槌狀趾
  • 糖尿病足病
  • 其他用途

第 10 章。全球足部和踝關節損傷市場(按最終用戶分類)

  • 醫院
  • 復健中心
  • 門診手術中心(ASC)
  • 整形外科診所
  • 其他最終用戶

第 11 章全球足部與踝關節損傷市場(按地區)

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第12章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第13章:企業概況

  • Johnson & Johnson
  • DJO Global
  • Medtronic Plc
  • Wright Medical Group NV
  • Stryker Corporation
  • BioPro Inc.
  • Zimmer Biomet Holdings, Inc.
  • Globus Medical
  • Smith & Nephew plc
  • Arthrex, Inc.
  • Orthofix Medical Inc.
  • Integra LifeSciences
  • Ossur
  • Acumed LLC
  • B. Braun Melsungen AG
Product Code: SMRC31493

According to Stratistics MRC, the Global Foot and Ankle Trauma Market is accounted for $2.02 billion in 2025 and is expected to reach $3.62 billion by 2032 growing at a CAGR of 8.7% during the forecast period. Foot and ankle trauma involves damage to the bones, muscles, ligaments, or soft tissues in the foot and ankle area, commonly resulting from falls, sports injuries, or accidents. Such trauma can vary from minor sprains to complex fractures and dislocations, necessitating early medical evaluation. Effective treatment, whether surgical or conservative, plays an essential role in ensuring recovery, maintaining mobility, and preventing long-term issues such as chronic discomfort or disability.

According to the WHO article published in May 2025, it causes approximately 1.19 million deaths annually and leaves 20-50 million individuals with non-fatal injuries.

Market Dynamics:

Driver:

Increasing geriatric population

The growing elderly population is significantly boosting demand for foot and ankle trauma care, as age-related musculoskeletal conditions become more prevalent. Osteoporosis, arthritis, and reduced bone density in older adults are contributing to higher fracture rates, particularly in the ankle region. Healthcare systems are responding by investing in advanced surgical tools tailored for geriatric patients. Minimally invasive procedures and robotic-assisted surgeries are gaining traction for their ability to reduce recovery time and improve precision. Innovations in imaging and diagnostics are enabling earlier detection and intervention for trauma cases in seniors. As life expectancy rises globally, the need for specialized orthopedic solutions continues to expand.

Restraint:

Lack of skilled professionals

Many regions, especially in developing countries, face challenges in recruiting and retaining skilled personnel for complex surgical procedures. The integration of AI and robotic systems into surgical workflows demands additional training, further widening the skills gap. Smaller healthcare facilities struggle to adopt advanced technologies due to limited access to qualified staff. This talent shortfall slows the adoption of innovative treatment methods and delays patient care. Addressing this issue requires coordinated efforts in medical education, certification programs, and global talent mobility.

Opportunity:

Increasing adoption of minimally invasive surgery

The shift toward minimally invasive techniques is opening new growth avenues in foot and ankle trauma care. These procedures offer reduced post-operative pain, faster healing, and lower infection risks, making them highly attractive to both patients and providers. Technological advancements such as endoscopic tools, 3D navigation systems, and robotic platforms are enhancing surgical accuracy. Hospitals and ambulatory centers are increasingly investing in compact, modular equipment designed for minimally invasive interventions. Emerging trends include augmented reality-assisted surgery and AI-driven preoperative planning. As reimbursement policies evolve to support these techniques, their adoption is expected to accelerate across global markets.

Threat:

Competition from substitute treatments

Alternative therapies such as regenerative medicine, physical rehabilitation, and orthotic devices pose a competitive threat to surgical interventions in foot and ankle trauma. Stem cell therapy and platelet-rich plasma injections are gaining popularity for their non-invasive nature and potential to promote natural healing. Wearable technologies and smart braces are also emerging as effective tools for managing minor fractures and sprains. These substitutes often appeal to patients seeking less invasive options with shorter recovery times. The rise of telemedicine and remote physiotherapy further expands access to non-surgical care. To stay competitive, surgical solution providers must emphasize superior outcomes and long-term benefits.

Covid-19 Impact:

The COVID-19 pandemic disrupted surgical care delivery, leading to postponed elective procedures and reduced trauma case volumes. Lockdowns and supply chain interruptions caused shortages in essential surgical instruments and implants. However, the crisis accelerated the adoption of digital health technologies, including remote diagnostics and virtual surgical planning. Hospitals began integrating telehealth platforms and AI-based triage systems to manage patient flow and prioritize urgent cases. Post-pandemic recovery strategies now focus on building resilient supply chains, automating surgical workflows, and decentralizing care delivery.

The Ankle fractures segment is expected to be the largest during the forecast period

The Ankle fractures segment is expected to account for the largest market share during the forecast period, due to its high incidence across all age groups. Sports injuries, falls, and vehicular accidents are major contributors to ankle trauma, driving demand for surgical repair tools. Hospitals are increasingly using advanced fixation devices, including bioresorbable screws and locking plates, to improve outcomes. Innovations in imaging, such as intraoperative CT and MRI, are enhancing precision during ankle surgeries. Emerging trends include personalized implants and 3D-printed bone scaffolds tailored to individual anatomy. As awareness grows and diagnostic capabilities improve, the ankle fracture segment continues to lead in market share.

The hospitals segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the hospitals segment is predicted to witness the highest growth rate, driven by infrastructure upgrades and technology adoption. These facilities are investing in robotic surgical systems, AI-powered diagnostics, and smart operating rooms to enhance procedural efficiency. The integration of electronic health records and cloud-based inventory systems is streamlining patient management and resource allocation. Hospitals are also expanding trauma centers and orthopedic departments to cater to rising demand. Key developments include partnerships with device manufacturers for real-time data analytics and remote monitoring.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, fueled by rapid healthcare expansion and rising surgical demand. Countries like China, India, and Japan are investing heavily in hospital modernization and local medical device production. Government initiatives are promoting import substitution and incentivizing domestic innovation in surgical technologies. The region is witnessing widespread adoption of robotic-assisted surgery and AI-based diagnostic platforms. Strategic collaborations between global OEMs and regional players are accelerating technology transfer and market penetration. With a growing middle class and aging population, Asia Pacific continues to lead in volume and infrastructure development.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by its leadership in surgical innovation and R&D. The U.S. and Canada are pioneering smart operating rooms, AI-enhanced diagnostics, and robotic-assisted orthopedic procedures. Regulatory bodies are streamlining approval pathways for next-gen surgical tools, enabling faster market entry. Hospitals are adopting IoT-based asset tracking and predictive analytics to optimize surgical workflows. The region benefits from strong reimbursement frameworks and high patient awareness of advanced treatment options.

Key players in the market

Some of the key players in Foot and Ankle Trauma Market include Johnson & Johnson, DJO Global, Medtronic Plc, Wright Medical Group N.V., Stryker Corporation, BioPro Inc., Zimmer Biomet Holdings, Inc., Globus Medical, Smith & Nephew plc, Arthrex, Inc., Orthofix Medical Inc., Integra LifeSciences, Ossur, Acumed LLC, and B. Braun Melsungen AG.

Key Developments:

In September 2025, The Johnson & Johnson (J&J) announced a $5 million investment in the Africa Frontline First (AFF) Catalytic Fund, a fund hosted by the Global Fund to Fight AIDS, TB & Malaria. As an AFF Catalytic Fund founding supporter, the J&J Foundation's total pledge has now increased to a total of $20 million for the training and deployment of 200,000 professional community health workers (CHWs) into national health systems across Africa.

In June 2025, Medtronic plc announced MiniMed as the name for the planned New Diabetes Company following the intended separation. The name honors the company's roots, reflecting its original name prior to its acquisition by Medtronic in 2001, and a deep 40-year history of being at the forefront of transforming diabetes care around the world.

Products Covered:

  • Orthopedic Implants and Devices
  • Bracing and Support Devices
  • Prostheses
  • Other Products

Injury Types Covered:

  • Hindfoot Fractures
  • Ankle Fractures
  • Midfoot & Lisfranc Injuries
  • Forefoot Fractures
  • Dislocations & Complex Trauma
  • Ligamentous Injuries & Instability

Treatments Covered:

  • Open Reduction and Internal Fixation (ORIF)
  • Non-Operative Management
  • Minimally Invasive Fixation
  • Revision & Reconstruction Surgeries
  • External Fixation Procedures
  • Arthrodesis

Distribution Channels Covered:

  • Direct Sales
  • Online Platforms
  • Distributors & Wholesalers
  • Group Purchasing Organizations (GPOs)

Applications Covered:

  • Trauma and Hairline Fractures
  • Ligament Injuries
  • Dislocations
  • Neurological Disorders
  • Rheumatoid Arthritis & Osteoarthritis
  • Hammertoe
  • Diabetic Foot Diseases
  • Other Applications

End Users Covered:

  • Hospitals
  • Rehabilitation Centers
  • Ambulatory Surgery Centers (ASCs)
  • Orthopedic Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Foot And Ankle Trauma Market, By Product

  • 5.1 Introduction
  • 5.2 Orthopedic Implants and Devices
    • 5.2.1 Plates and Screws
    • 5.2.2 External Fixators
    • 5.2.3 Intramedullary Nails
  • 5.3 Bracing and Support Devices
  • 5.4 Prostheses
  • 5.5 Other Products

6 Global Foot And Ankle Trauma Market, By Injury Type

  • 6.1 Introduction
  • 6.2 Hindfoot Fractures
  • 6.3 Ankle Fractures
  • 6.4 Midfoot & Lisfranc Injuries
  • 6.5 Forefoot Fractures
  • 6.6 Dislocations & Complex Trauma
  • 6.7 Ligamentous Injuries & Instability

7 Global Foot And Ankle Trauma Market, By Treatment

  • 7.1 Introduction
  • 7.2 Open Reduction and Internal Fixation (ORIF)
  • 7.3 Non-Operative Management
  • 7.4 Minimally Invasive Fixation
  • 7.5 Revision & Reconstruction Surgeries
  • 7.6 External Fixation Procedures
  • 7.7 Arthrodesis

8 Global Foot And Ankle Trauma Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Direct Sales
  • 8.3 Online Platforms
  • 8.4 Distributors & Wholesalers
  • 8.5 Group Purchasing Organizations (GPOs)

9 Global Foot And Ankle Trauma Market, By Application

  • 9.1 Introduction
  • 9.2 Trauma and Hairline Fractures
  • 9.3 Ligament Injuries
  • 9.4 Dislocations
  • 9.5 Neurological Disorders
  • 9.6 Rheumatoid Arthritis & Osteoarthritis
  • 9.7 Hammertoe
  • 9.8 Diabetic Foot Diseases
  • 9.9 Other Applications

10 Global Foot And Ankle Trauma Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals
  • 10.3 Rehabilitation Centers
  • 10.4 Ambulatory Surgery Centers (ASCs)
  • 10.5 Orthopedic Clinics
  • 10.6 Other End Users

11 Global Foot And Ankle Trauma Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Johnson & Johnson
  • 13.2 DJO Global
  • 13.3 Medtronic Plc
  • 13.4 Wright Medical Group N.V.
  • 13.5 Stryker Corporation
  • 13.6 BioPro Inc.
  • 13.7 Zimmer Biomet Holdings, Inc.
  • 13.8 Globus Medical
  • 13.9 Smith & Nephew plc
  • 13.10 Arthrex, Inc.
  • 13.11 Orthofix Medical Inc.
  • 13.12 Integra LifeSciences
  • 13.13 Ossur
  • 13.14 Acumed LLC
  • 13.15 B. Braun Melsungen AG

List of Tables

  • Table 1 Global Foot And Ankle Trauma Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Foot And Ankle Trauma Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Foot And Ankle Trauma Market Outlook, By Orthopedic Implants and Devices (2024-2032) ($MN)
  • Table 4 Global Foot And Ankle Trauma Market Outlook, By Plates and Screws (2024-2032) ($MN)
  • Table 5 Global Foot And Ankle Trauma Market Outlook, By External Fixators (2024-2032) ($MN)
  • Table 6 Global Foot And Ankle Trauma Market Outlook, By Intramedullary Nails (2024-2032) ($MN)
  • Table 7 Global Foot And Ankle Trauma Market Outlook, By Bracing and Support Devices (2024-2032) ($MN)
  • Table 8 Global Foot And Ankle Trauma Market Outlook, By Prostheses (2024-2032) ($MN)
  • Table 9 Global Foot And Ankle Trauma Market Outlook, By Other Products (2024-2032) ($MN)
  • Table 10 Global Foot And Ankle Trauma Market Outlook, By Injury Type (2024-2032) ($MN)
  • Table 11 Global Foot And Ankle Trauma Market Outlook, By Hindfoot Fractures (2024-2032) ($MN)
  • Table 12 Global Foot And Ankle Trauma Market Outlook, By Ankle Fractures (2024-2032) ($MN)
  • Table 13 Global Foot And Ankle Trauma Market Outlook, By Midfoot & Lisfranc Injuries (2024-2032) ($MN)
  • Table 14 Global Foot And Ankle Trauma Market Outlook, By Forefoot Fractures (2024-2032) ($MN)
  • Table 15 Global Foot And Ankle Trauma Market Outlook, By Dislocations & Complex Trauma (2024-2032) ($MN)
  • Table 16 Global Foot And Ankle Trauma Market Outlook, By Ligamentous Injuries & Instability (2024-2032) ($MN)
  • Table 17 Global Foot And Ankle Trauma Market Outlook, By Treatment (2024-2032) ($MN)
  • Table 18 Global Foot And Ankle Trauma Market Outlook, By Open Reduction and Internal Fixation (ORIF) (2024-2032) ($MN)
  • Table 19 Global Foot And Ankle Trauma Market Outlook, By Non-Operative Management (2024-2032) ($MN)
  • Table 20 Global Foot And Ankle Trauma Market Outlook, By Minimally Invasive Fixation (2024-2032) ($MN)
  • Table 21 Global Foot And Ankle Trauma Market Outlook, By Revision & Reconstruction Surgeries (2024-2032) ($MN)
  • Table 22 Global Foot And Ankle Trauma Market Outlook, By External Fixation Procedures (2024-2032) ($MN)
  • Table 23 Global Foot And Ankle Trauma Market Outlook, By Arthrodesis (2024-2032) ($MN)
  • Table 24 Global Foot And Ankle Trauma Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 25 Global Foot And Ankle Trauma Market Outlook, By Direct Sales (2024-2032) ($MN)
  • Table 26 Global Foot And Ankle Trauma Market Outlook, By Online Platforms (2024-2032) ($MN)
  • Table 27 Global Foot And Ankle Trauma Market Outlook, By Distributors & Wholesalers (2024-2032) ($MN)
  • Table 28 Global Foot And Ankle Trauma Market Outlook, By Group Purchasing Organizations (GPOs) (2024-2032) ($MN)
  • Table 29 Global Foot And Ankle Trauma Market Outlook, By Application (2024-2032) ($MN)
  • Table 30 Global Foot And Ankle Trauma Market Outlook, By Trauma and Hairline Fractures (2024-2032) ($MN)
  • Table 31 Global Foot And Ankle Trauma Market Outlook, By Ligament Injuries (2024-2032) ($MN)
  • Table 32 Global Foot And Ankle Trauma Market Outlook, By Dislocations (2024-2032) ($MN)
  • Table 33 Global Foot And Ankle Trauma Market Outlook, By Neurological Disorders (2024-2032) ($MN)
  • Table 34 Global Foot And Ankle Trauma Market Outlook, By Rheumatoid Arthritis & Osteoarthritis (2024-2032) ($MN)
  • Table 35 Global Foot And Ankle Trauma Market Outlook, By Hammertoe (2024-2032) ($MN)
  • Table 36 Global Foot And Ankle Trauma Market Outlook, By Diabetic Foot Diseases (2024-2032) ($MN)
  • Table 37 Global Foot And Ankle Trauma Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 38 Global Foot And Ankle Trauma Market Outlook, By End User (2024-2032) ($MN)
  • Table 39 Global Foot And Ankle Trauma Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 40 Global Foot And Ankle Trauma Market Outlook, By Rehabilitation Centers (2024-2032) ($MN)
  • Table 41 Global Foot And Ankle Trauma Market Outlook, By Ambulatory Surgery Centers (ASCs) (2024-2032) ($MN)
  • Table 42 Global Foot And Ankle Trauma Market Outlook, By Orthopedic Clinics (2024-2032) ($MN)
  • Table 43 Global Foot And Ankle Trauma Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.